News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
557,404 Results
Type
Article (34544)
Company Profile (162)
Press Release (522693)
Multimedia
Podcasts (75)
Webinars (12)
Section
Business (155264)
Career Advice (747)
Deals (25329)
Drug Delivery (82)
Drug Development (59889)
Employer Resources (80)
FDA (14382)
Job Trends (11953)
News (260324)
Policy (24285)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (2318)
Accelerated approval (19)
Adcomms (10)
Allergies (128)
Alliances (43658)
ALS (114)
Alzheimer's disease (1253)
Antibody-drug conjugate (ADC) (246)
Approvals (14729)
Artificial intelligence (493)
Autoimmune disease (119)
Automation (33)
Bankruptcy (211)
Best Places to Work (9743)
BIOSECURE Act (10)
Biosimilars (92)
Biotechnology (118)
Bladder cancer (132)
Brain cancer (48)
Breast cancer (496)
Cancer (3839)
Cardiovascular disease (305)
Career advice (678)
Career pathing (20)
CAR-T (244)
CDC (29)
Celiac Disease (2)
Cell therapy (629)
Cervical cancer (35)
Clinical research (51979)
Collaboration (1507)
Compensation (438)
Complete response letters (23)
COVID-19 (2104)
CRISPR (89)
C-suite (696)
Cystic fibrosis (99)
Data (5096)
Decentralized trials (2)
Denatured (37)
Depression (102)
Diabetes (388)
Diagnostics (6116)
Digital health (41)
Diversity (11)
Diversity, equity & inclusion (17)
Drug discovery (206)
Drug pricing (101)
Drug shortages (24)
Duchenne muscular dystrophy (170)
Earnings (57540)
Editorial (34)
Employer branding (12)
Employer resources (73)
Events (80420)
Executive appointments (805)
FDA (17098)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (14)
Funding (1168)
Gene editing (184)
Generative AI (43)
Gene therapy (464)
GLP-1 (701)
Government (3594)
Grass and pollen (6)
Guidances (322)
Healthcare (15609)
HIV (49)
Huntington's disease (25)
IgA nephropathy (60)
Immunology and inflammation (120)
Immuno-oncology (33)
Indications (84)
Infectious disease (2312)
Inflammatory bowel disease (143)
Inflation Reduction Act (8)
Influenza (97)
Intellectual property (192)
Interviews (78)
IPO (11005)
IRA (29)
Job creations (2571)
Job search strategy (598)
JPM (30)
Kidney cancer (12)
Labor market (49)
Layoffs (283)
Leadership (12)
Legal (4977)
Liver cancer (77)
Longevity (11)
Lung cancer (548)
Lymphoma (303)
Machine learning (38)
Management (30)
Manufacturing (612)
MASH (121)
Medical device (14460)
Medtech (14512)
Mergers & acquisitions (15108)
Metabolic disorders (910)
Multiple sclerosis (123)
NASH (12)
Neurodegenerative disease (225)
Neuropsychiatric disorders (52)
Neuroscience (2152)
NextGen: Class of 2026 (5402)
Non-profit (3424)
Now hiring (39)
Obesity (374)
Opinion (164)
Ovarian cancer (145)
Pain (174)
Pancreatic cancer (170)
Parkinson's disease (208)
Partnered (25)
Patents (393)
Patient recruitment (411)
Peanut (53)
People (48866)
Pharmaceutical (29)
Pharmacy benefit managers (17)
Phase 1 (16105)
Phase 2 (22700)
Phase 3 (17501)
Pipeline (4092)
Policy (159)
Postmarket research (1809)
Preclinical (6229)
Press Release (67)
Prostate cancer (199)
Psychedelics (27)
Radiopharmaceuticals (240)
Rare diseases (569)
Real estate (4667)
Recruiting (33)
Regulatory (19218)
Reports (22)
Research institute (2139)
Resumes & cover letters (102)
Rett syndrome (26)
RNA editing (11)
RSV (58)
Schizophrenia (123)
Series A (194)
Series B (143)
Service/supplier (7)
Sickle cell disease (61)
Special edition (7)
Spinal muscular atrophy (120)
Sponsored (30)
Startups (3235)
State (2)
Stomach cancer (12)
Supply chain (78)
Tariffs (31)
The Weekly (37)
Vaccines (772)
Venture capital (53)
Weight loss (239)
Women's health (70)
Worklife (6)
Date
Today (39)
Last 7 days (423)
Last 30 days (1492)
Last 365 days (22675)
2026 (2119)
2025 (23111)
2024 (27744)
2023 (31914)
2022 (42306)
2021 (45750)
2020 (44558)
2019 (39088)
2018 (29737)
2017 (26810)
2016 (25741)
2015 (30022)
2014 (22806)
2013 (19194)
2012 (20786)
2011 (21274)
2010 (19632)
Location
Africa (532)
Alabama (76)
Alaska (6)
Arizona (241)
Arkansas (13)
Asia (35093)
Australia (5912)
California (8099)
Canada (2638)
China (982)
Colorado (376)
Connecticut (399)
Delaware (287)
Europe (74316)
Florida (1340)
Georgia (301)
Hawaii (3)
Idaho (50)
Illinois (716)
India (45)
Indiana (438)
Iowa (17)
Japan (405)
Kansas (121)
Kentucky (28)
Louisiana (22)
Maine (36)
Maryland (1137)
Massachusetts (5547)
Michigan (321)
Minnesota (519)
Mississippi (5)
Missouri (120)
Montana (30)
Nebraska (26)
Nevada (84)
New Hampshire (83)
New Jersey (2433)
New Mexico (22)
New York (2189)
North Carolina (1127)
North Dakota (10)
Northern California (3773)
Ohio (286)
Oklahoma (18)
Oregon (37)
Pennsylvania (1687)
Puerto Rico (22)
Rhode Island (43)
South America (779)
South Carolina (66)
South Dakota (1)
Southern California (3245)
Tennessee (144)
Texas (1340)
United States (30122)
Utah (288)
Vermont (1)
Virginia (179)
Washington D.C. (58)
Washington State (710)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
557,404 Results for "helius medical technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
June 5, 2025
·
4 min read
Press Releases
Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria
June 5, 2025
·
2 min read
Pharm Country
Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference 2024
Helius Medical Technologies, Inc. announced that it will participate in the Spring MicroCap Rodeo Conference to be held on Thursday, June 6th in NYC.
May 31, 2024
·
6 min read
Press Releases
Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
May 12, 2025
·
5 min read
Press Releases
Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke
September 25, 2025
·
8 min read
Business
Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced results for the quarter ended March 31, 2024.
May 13, 2024
·
10 min read
Pharm Country
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
Helius Medical Technologies, Inc. today announced the expansion of its clinical development program for the broadening of the labeling of its marketed PoNS device.
April 24, 2024
·
7 min read
Press Releases
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
March 13, 2025
·
5 min read
Pharm Country
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke
Helius Medical Technologies, Inc. today announced the initiation of an open-label study for its registrational program in stroke.
March 12, 2024
·
7 min read
Business
Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024
Helius Medical Technologies, Inc. today announced that the Company will release its first quarter 2024 financial results on Monday, May 13, 2024, after the market closes.
May 10, 2024
·
2 min read
1 of 55,741
Next
